Musings of a Neurosurgeon · Peer-reviewed resource since 2010 News & Updates · Forum

Deep brain stimulation for essential tremor in Australia

Deep brain stimulation (DBS) for essential tremor can provide adjustable, long-term control of severe action tremor when medication no longer gives an acceptable result. It is most reliable for hand tremor, including postural and intention tremor during eating, writing, drinking, and work. DBS does not cure essential tremor, and benefit for head, voice, gait, and balance is less predictable. Careful selection, exact electrode placement, and sustained programming matter as much as the implanted device.

The strongest candidates have a confirmed diagnosis and tremor that causes substantial functional or social disability despite adequate, tolerated medication trials. In Australia, assessment usually occurs through a multidisciplinary DBS service involving a neurologist, neurosurgeon, neuropsychologist, physiotherapist, and allied health staff. The pathway may run through the public system, where triage and waiting lists apply, or through private cover, but the clinical standards should be identical. This guide concentrates on selection, surgical decisions, and follow-up.

Who is most likely to benefit

Essential tremor is usually an action and postural tremor, although rest tremor can occur. Parkinson disease should be considered when bradykinesia, rigidity, reduced arm swing, or a clear levodopa response is present; dystonic tremor, cerebellar disease, vascular lesions, neuropathic tremor, and medication effects can also mimic it. A movement-disorders assessment is therefore more informative than labelling every visible tremor essential tremor.

The practical threshold is not tremor amplitude alone. Writing, eating, dressing, work tasks, and social confidence may be affected even when standardised scores look modest. DBS is generally considered for disabling, medication-refractory tremor after goals are agreed in functional terms. A well-informed patient who can attend programming sessions and use available assistive devices usually has a better chance of gaining meaningful function.

Age alone should not decide candidacy. Frailty, balance risk, cognition, mood, falls, communication, and the ability to manage postoperative care are more relevant. Severe dementia, active infection, uncorrected coagulopathy, or uncontrolled psychiatric illness may make implantation unsafe; some issues can be addressed before proceeding. Expectations should focus on hand control and defined activities rather than a cure.

Confirming the diagnosis and baseline disability

Medication response should be established before surgery. Propranolol and primidone are standard first-line options in Australia, while topiramate is another commonly considered drug; botulinum toxin may help selected focal or vocal presentations. Clinicians should record dose, duration, benefit, and adverse effects for each trial. Standardised scales such as TETRAS or CRST, timed tasks, and simple video or home recordings make change easier to judge.

Neuroimaging is not routinely required for straightforward essential tremor, but the onset pattern and neurological examination guide further testing. Sudden onset, marked asymmetry, cerebellar signs, or a poor levodopa response warrant review for another diagnosis. A baseline neuropsychological assessment can identify cognitive or mood problems that affect safety, decision-making, or the ability to use stimulation effectively. Depression, impulsivity, and medication-related sleepiness should be treated and monitored before consent.

The Australian pathway commonly begins with a GP—often bulk-billed for the consultation—and a referral for specialist assessment with a Medicare rebate. Public patients are triaged through state services and may join a waiting list; privately insured patients usually need a referral to a DBS surgeon. The operation, hospital care, and implant are generally handled through public hospital funding or private cover rather than the PBS outpatient medicines scheme, so eligibility and out-of-pocket costs should be confirmed early.

Multidisciplinary DBS teams are concentrated in metropolitan teaching hospitals, leaving some regional, rural, and remote patients facing travel, accommodation, and repeated follow-up trips. Referral networks may involve tertiary programs in Melbourne, Sydney, Brisbane and Adelaide, depending on state arrangements. Telehealth can support medication review but cannot replace in-person wound checks, programming, or imaging. Medication access also warrants attention: rural pharmacy surveillance can reveal uneven availability, and access or adherence should be reviewed before medication failure is accepted. For Aboriginal and Torres Strait Islander patients, culturally safe communication, interpreter access, and patient-preferred family or community involvement should be offered.

Selecting the target and trajectory

The usual target is the ventral intermediate nucleus of the thalamus, often called the VIM. Some teams also use nearby posterior subthalamic or dentato-rubro-thalamic structures for tremor control. Directional leads can steer current toward a smaller area and away from side-effect-producing fibres, but availability varies across Australian services. Device capability should support, rather than dictate, the clinical plan.

Trajectory can be as important as the nominal target. The path should avoid surface vessels and minimise proximity to corticospinal, sensory, and other pathways that can produce weakness, numbness, dysarthria, or ataxia. Microelectrode recording and test stimulation help map anatomy and identify a contact that suppresses tremor without adverse effects. No single coordinate should be accepted without patient-specific physiologic confirmation.

Side selection usually begins with the more affected hand, particularly when asymmetry is marked. Bilateral treatment may provide the best functional control for severe two-sided tremor, but it doubles the implanted hardware and potential complications. Some surgeons use staged insertion so that the first side can be assessed before committing to the second; others operate on both sides in one session. The choice depends on anatomy, comorbidity, operative risk, and the patient’s priorities.

Operative technique and safety

In an awake procedure, microelectrode recording maps the thalamic region, and test stimulation checks tremor suppression and adverse effects. Paraesthesia, dysarthria, ataxia, diplopia, or gait disturbance may indicate that stimulation is reaching an unsuitable structure or contact. Asleep implantation with intraoperative test stimulation is an alternative when awake cooperation is unsuitable, though it may reduce the detail available during target confirmation.

After target confirmation, the lead is fixed with minimal tension and connected to an extension and implantable pulse generator through a carefully tunnelled path. The generator is placed in a comfortable, protected pocket, with attention to shoulder motion and device erosion. Antibiotics, haemostasis, traction-free fixation, and intraoperative impedance checks reduce infection, haematoma, and hardware-related risk. Each side is tested before wound closure, with the final trajectory documented for programming.

Postoperative imaging and neurological observation are important because intracranial haemorrhage, infarction, seizure, confusion, infection, or lead migration may occur. New weakness, severe headache, seizure, reduced consciousness, or rapidly changing wound appearance requires urgent assessment rather than routine programming. A structured consciousness assessment, including the Glasgow Coma Scale, can support handover and escalation, but it does not replace urgent imaging or neurosurgical review. Patients in Australia should receive clear postoperative instructions and be told to call 000 for an emergency.

Programming, follow-up, and outcomes

Programming begins once the patient is clinically stable and the surgical site has healed sufficiently. Clinicians gradually increase amplitude, select contacts, and adjust frequency or pulse width while checking tremor control, speech, balance, sensation, and cognition. Antithrombotic medication and tremor medicines should be changed only with the treating team, and drug reductions should be gradual. Occupational therapy and physiotherapy can help patients convert reduced tremor into better handwriting, eating, and workplace performance.

Results are strongest for hand tremor; improvements in axial tremor, voice, and cognition are not reliably achieved. Long-term care includes medication review, adverse-effect monitoring, battery assessment, and inspection for infection, migration, or hardware failure. Remote monitoring may assist between visits, although access and device support vary by provider and location. Patients should know that further adjustments are normal and that the original functional goals should guide programming decisions.

Option Most suitable situation Main advantages Important limitations
Optimised medication Initial treatment and mild to moderate disability Non-invasive, reversible, lower procedural risk Side effects, adherence, and declining efficacy
Deep brain stimulation Severe, bilateral, medication-refractory hand tremor Adjustable bilateral treatment; symptom control can be modified over time Brain surgery, device complications, ongoing programming
Focused ultrasound Selected unilateral hand tremor when surgery is declined or unsuitable Incisionless and no implanted device Usually unilateral, skull-related eligibility, transient gait or sensory effects

Taking the next step in Australia

Patients ready to explore surgery should request a movement-disorders referral from their GP or neurologist, bring a complete medication history, and record task-specific tremor such as writing, drinking, and eating. The assessing team can clarify whether public-hospital or private pathways suit the patient, estimate travel from regional areas, and explain whether DBS, focused ultrasound, or further medical treatment best matches the goals.

Clinicians can contribute de-identified cases and structured outcome measures to the open peer discussion forum, while the curated e-library supports evidence-based referral and follow-up. Registered members can post, reply, subscribe to updates, and compare management decisions with colleagues across Australia. Start with a structured referral, a complete medication record, and shared functional goals.